Table 1. Participants Baseline Characteristics.
| Aerobic Group (N = 13) | Resistance Group (N = 12) | P value | |
| Men/Women (n) | 9/4 | 7/5 | 0.69 |
| Age (years) | 57.0±2.1 | 56.1±2.4 | 0.76 |
| BMI (kg/m2) | 29.5±1.2 | 31.6±1.2 | 0.22 |
| Duration of Diabetes (years) | 10.7±1.8 | 9.2±2.7 | 0.66 |
| HbA1c (%) | 7.3±0.2 | 7.5±0.2 | 0.54 |
| Antidiabetic Therapy (n) | 0.64 | ||
| Diet alone | 1 | 0 | |
| Metformin | 7 | 7 | |
| Thiazolidinediones | 2 | 0 | |
| Sulfonylureas | 0 | 1 | |
| Meglitinides | 0 | 1 | |
| Metformin and Sulfonylureas | 3 | 2 | |
| Metformin and Meglitinides | 0 | 1 | |
| VO2peak (mL·kg−1·min−1) | 25.5±0.9 | 24.8±1.6 | 0.71 |
| Overall physical activity (MET min per week) | 329±63 | 255±64 | 0.42 |
| Caloric Intake (Kcal/day) | 1468±122 | 1373±68 | 0.31 |
Values are mean±SE unless otherwise specified.